Volume 31, Issue 1, Pages (July 2009)

Slides:



Advertisements
Similar presentations
Volume 39, Issue 5, Pages (November 2013)
Advertisements

Induction of Apoptosis by Crambene Protects Mice against Acute Pancreatitis via Anti- Inflammatory Pathways  Yang Cao, Sharmila Adhikari, Marie Véronique.
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 39, Issue 3, Pages (September 2013)
Volume 43, Issue 6, Pages (December 2015)
Volume 42, Issue 1, Pages (January 2015)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Community Behavior and Spatial Regulation within a Bacterial Microcolony in Deep Tissue Sites Serves to Protect against Host Attack  Kimberly M. Davis,
Volume 42, Issue 3, Pages (March 2015)
Volume 36, Issue 6, Pages (June 2012)
Suk-Jo Kang, Hong-Erh Liang, Boris Reizis, Richard M. Locksley 
Volume 31, Issue 2, Pages (August 2009)
Volume 8, Issue 4, Pages (October 2008)
WanJun Chen, Mark E Frank, Wenwen Jin, Sharon M Wahl  Immunity 
Volume 26, Issue 5, Pages (May 2007)
Volume 43, Issue 3, Pages (September 2015)
Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission  Yongjun Tian,
Volume 37, Issue 6, Pages (December 2012)
Volume 39, Issue 5, Pages (November 2013)
Volume 33, Issue 2, Pages (August 2010)
Timothy E. O’Sullivan, Lexus R. Johnson, Helen H. Kang, Joseph C. Sun 
Activation of the Innate Signaling Molecule MAVS by Bunyavirus Infection Upregulates the Adaptor Protein SARM1, Leading to Neuronal Death  Piyali Mukherjee,
Volume 141, Issue 1, Pages (July 2011)
Volume 29, Issue 2, Pages (August 2008)
Volume 4, Issue 4, Pages (October 2008)
Volume 29, Issue 2, Pages (August 2008)
Volume 42, Issue 5, Pages (May 2015)
Volume 31, Issue 1, Pages (July 2009)
Volume 43, Issue 4, Pages (October 2015)
Volume 24, Issue 3, Pages (March 2006)
Volume 14, Issue 1, Pages (January 2004)
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Nelson C Di Paolo, Nico van Rooijen, Dmitry M Shayakhmetov 
Volume 29, Issue 6, Pages (December 2008)
Volume 3, Issue 6, Pages (June 2013)
Volume 47, Issue 2, Pages e5 (August 2017)
Volume 47, Issue 4, Pages e3 (October 2017)
S100A15, an Antimicrobial Protein of the Skin: Regulation by E
Volume 27, Issue 2, Pages (August 2007)
Volume 4, Issue 5, Pages (November 2008)
Volume 29, Issue 2, Pages (August 2008)
Induction of Hepatitis by JNK-Mediated Expression of TNF-α
A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses  Guangxun Meng, Fuping Zhang, Ivan Fuss,
B Cell Receptor and CD40 Signaling Are Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells  Wei Luo, Florian.
Volume 36, Issue 2, Pages (February 2012)
Volume 25, Issue 7, Pages (July 2017)
Volume 22, Issue 2, Pages (February 2005)
Volume 41, Issue 4, Pages (October 2014)
Francis Coffey, Boris Alabyev, Tim Manser  Immunity 
Marginal Zone and B1 B Cells Unite in the Early Response against T-Independent Blood-Borne Particulate Antigens  Flavius Martin, Alyce M Oliver, John.
Volume 30, Issue 2, Pages (February 2009)
Volume 14, Issue 2, Pages (August 2013)
Volume 6, Issue 1, Pages (July 2009)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
Myung H. Kim, Elizabeth J. Taparowsky, Chang H. Kim  Immunity 
Cell-Intrinsic IL-27 and gp130 Cytokine Receptor Signaling Regulates Virus-Specific CD4+ T Cell Responses and Viral Control during Chronic Infection 
Volume 31, Issue 4, Pages (October 2009)
Volume 42, Issue 4, Pages (April 2015)
Volume 34, Issue 5, Pages (May 2011)
Volume 40, Issue 4, Pages (April 2014)
Volume 37, Issue 1, Pages (July 2012)
Volume 28, Issue 5, Pages (May 2008)
Volume 30, Issue 4, Pages (April 2009)
Volume 7, Issue 5, Pages (May 2010)
Volume 27, Issue 4, Pages (October 2007)
Volume 9, Issue 6, Pages (June 2011)
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Volume 25, Issue 6, Pages (June 2017)
Volume 21, Issue 1, Pages (January 2017)
Presentation transcript:

Volume 31, Issue 1, Pages 110-121 (July 2009) Virus Binding to a Plasma Membrane Receptor Triggers Interleukin-1α-Mediated Proinflammatory Macrophage Response In Vivo  Nelson C. Di Paolo, Edward A. Miao, Yoichiro Iwakura, Kaja Murali-Krishna, Alan Aderem, Richard A. Flavell, Thalia Papayannopoulou, Dmitry M. Shayakhmetov  Immunity  Volume 31, Issue 1, Pages 110-121 (July 2009) DOI: 10.1016/j.immuni.2009.04.015 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 Splenic Marginal Zone Macrophages Trap Adenovirus and Initiate an IL-1RI-Dependent Innate Immune Response In Vivo (A) Distribution of Ad particles in the spleen 30 min after virus injection. RP, red pulp; GC, germinal center; MZ, marginal zone. Ad antibody stain is red. (B and C) Colocalization of Ad particles (red) with (B) CD169- or (C) MARCO-positive macrophages in the splenic MZ. (D) mRNA expression for IL-1α, IL-1β, CXCL1, and CXCL2 in the spleen 30 min after Ad injection. Graphs show mean ± SD, n = 4. ∗p < 0.01. Except for the columns indicated by the star, no statistically significant differences between experimental groups and WT group were identified (p > 0.05). C, mock-infected mice, treated with saline; AU, arbitrary units. (E and F) Kinetics of the transcriptional activation of Il1a, Il1b, Cxcl1, and Cxcl2 in wild-type (E) or Il1r1−/− (F) mice analyzed by the RNase protection assay. Representative gels with mRNA for corresponding cytokines and chemokines are shown. Individual mice were injected with Ad and sacrificed at indicated time points. (G) Mouse cytokine array panel showing differences in the proinflammatory cytokines and chemokines in spleen of wild-type (WT) and Il1r1−/− mice 1 hr after Ad injection, determined by Proteome Profiler antibody array. Representative blot from four independent experiments is shown. As a positive control for inflammatory cytokine and chemokine induction, mice were injected with LPS. (H) The amounts of proinflammatory cytokines and chemokines in the spleens of mice 1 hr after Ad injection. The amounts of analytes shown on y axis were determined for 50 mg of splenic tissue. Graphs show means ± SD. n = 3. Mock, negative control mice injected with saline; ∗p < 0.01. Immunity 2009 31, 110-121DOI: (10.1016/j.immuni.2009.04.015) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 IL-1α Is the Dominant Mediator of an Innate Immune Response to Ad In Vivo (A) The mRNA expression for IL-1α, IL-1β, CXCL1, and CXCL2 in spleens of mice 30 min after Ad injection, analyzed by the RNase protection assay. Representative gels with mRNA for corresponding cytokines and chemokines are shown in biological duplicates. n = 3. C, mock-infected mice, injected with saline. (B) Quantitative representation of mRNA expression from the gel shown in (A) after phosphorimager analysis. Graphs show mean ± SD. n = 6. n.s., not statistically significant. ∗p < 0.01. AU, arbitrary units. (C) IL-1α, IL-1β, and CXCL2 mRNA in livers of mice 30 min after Ad injection analyzed by the RNase protection assay. Data are representative of three independent experiments. (D) Quantitative representation of mRNA expression from the gel shown in (C) after phosphorimager analysis. Graphs show mean ± SD. n = 6. n.s., not statistically significant. ∗p < 0.01. (E) Mouse cytokine array panel showing differences in the proinflammatory cytokines and chemokines in spleen of wild-type (WT) and Il1a−/−, Il1b−/−, and Il1a−/−b−/− mice 1 hr after Ad injection, determined by Proteome Profiler antibody array. Representative blot from four independent experiments is shown. Pos-C are dots that show the manufacturer's internal positive control samples on the membrane. Control, the spleen protein sample of a mouse injected with saline. (F) The amounts of proinflammatory cytokines and chemokines in the spleens of mice 1 hr after Ad injection. The amounts of analytes shown on y axis were determined for 50 mg of splenic tissue. Graphs show means ± SD. n = 4. Mock, negative control mice injected with saline. n.s., not statistically significant. ∗p < 0.01. Immunity 2009 31, 110-121DOI: (10.1016/j.immuni.2009.04.015) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 Ad Induces Expression of IL-1α and Its Translocation to the Nuclei in Marginal Zone Macrophages (A–C) Immunofluorescent and confocal microscopy analysis of IL-1α expression on spleen sections of (A) mock-injected or (B) Ad-injected mice at 1 hr or (C) 3 hr after injection. The physical border of the germinal centers are depicted by punctuate lines. (D–F) Confocal microscopy analysis of colocalization of IL-1α-positive staining with marginal zone macrophage staining. Arrows indicate CD169-positive cells in the marginal zone, colocalized with IL-1α-positive staining. Representative pictures are shown. n = 5. (G–I) Confocal microscopy analysis shows the colocalization of nuclei of splenic marginal zone cells stained with (G) DAPI (blue), (H) IL-1α (red), and (I) CD169 macrophage marker. Macrophage cells with colocalized DAPI and IL-1α staining are shown by arrows. (J) Semiquantitative presentation of the percentage of IL-1α-expressing marginal zone cells with IL-1α-positive nuclei in mock-injected mice and Ad-injected mice. The nuclear IL-1α-positive staining was analyzed in 200 IL-1α-positive cells on spleen sections of the Ad-injected group. No IL-1α-positive nuclei were found on spleen sections of mock-injected animals. n = 6. ∗p < 0.01. Immunity 2009 31, 110-121DOI: (10.1016/j.immuni.2009.04.015) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 4 Activation of an IL-1α-Mediated Innate Response to Ad Does Not Depend on NLRP3 Inflammasome, MyD88, TRIF, or TRAF6 (A) The mRNA expression for IL-1α, IL-1β, CXCL1, and CXCL2 in spleens of mice 30 min after Ad injection, analyzed by the RNase protection assay, and quantified after phosphorimager analysis of the RNA gels. C, mock-infected mice, injected with saline. Graphs show mean ± SD. n = 4. Except for the columns indicated by the star, no statistically significant differences between experimental groups and WT group were identified (p > 0.05). ∗p < 0.01. AU, arbitrary units. (B) Mouse cytokine array panel showing differences in the proinflammatory cytokines and chemokines in spleen of wild-type (WT) and Nlrp3−/−, Pycard−/−, Casp1−/−, and Il1r1−/− mice 1 hr after Ad injection, determined by Proteome Profiler antibody array. Representative blot from three independent experiments is shown. Pos-C are dots that show the manufacturer's internal positive control samples on the membrane. Mock, the spleen protein sample of a mouse injected with saline. (C) The amounts of proinflammatory cytokines and chemokines in the spleens of mice 1 hr after Ad injection. The amounts of analytes shown on y axis were determined for 50 mg of splenic tissue. Graphs show means ± SD. n = 4. Mock, negative control mice injected with saline. n.s., not statistically significant. (D) IL-1α, CXCL1, and CXCL2 mRNA levels in spleens of mice 30 min after Ad injection, determined by the RNase protection assay and quantified after phosphorimager analysis of the RNA gels. Graphs show mean ± SD. n = 4. ∗p < 0.01. C, mock-infected mice, treated with saline. n.s., not statistically significant. Immunity 2009 31, 110-121DOI: (10.1016/j.immuni.2009.04.015) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 5 The Engagement of β3 Integrins by Ad Is Critical for Initiation of the Innate Immune Response (A) The mRNA expression for IL-1α, IL-1β, CXCL1, and CXCL2 in spleens of wild-type mice (WT) and h-Itgb1−/−, Itgb3−/−, Itgb5−/− mice, as well as WT mice injected with Ad mutant lacking RGD amino acid motif (AdΔRGD) 30 min after Ad injection, analyzed by the RNase protection assay. Representative gels with mRNA for corresponding cytokines and chemokines are shown in biological duplicates. n = 3. C, mock-infected mice, injected with saline. (B) Quantitative representation of mRNA expression from the gel shown in (A) after phosphorimager analysis. Graphs show mean ± SD. Statistically significant differences between experimental groups and mock-injected controls (indicated by C) or WT injected with Ad are indicated by the star. ∗p < 0.01. WT mice injected with AdΔRGD are indicated by the arrow. AU, arbitrary units. n = 6. (C) IL-1α, IL-1β, and CXCL2 mRNA in livers of mice 30 min after Ad injection analyzed by the RNase protection assay. Data are representative of three independent experiments. (D) Quantitative representation of mRNA expression from the gel shown in (C) after phosphorimager analysis. Graphs show mean ± SD. n = 6. Statistically significant differences between experimental groups and WT mice injected with Ad are indicated by the star. ∗p < 0.01. (E) Mouse cytokine array panel showing differences in the proinflammatory cytokines and chemokines in spleen of wild-type (WT) and h-Itgb1−/−, Itgb2−/−, Itgb3−/− mice or WT mice injected with Ad or AdΔRGD 1 hr after virus injection, determined by Proteome Profiler antibody array. Representative blot from four independent experiments is shown. Pos-C are dots that show the manufacturer's internal positive control samples on the membrane. Control, the spleen protein sample of a mouse injected with saline. (F) The amounts of proinflammatory cytokines and chemokines in the spleens of mice 1 hr after Ad injection. The amounts of analytes shown on y axis were determined for 50 mg of splenic tissue. Graphs show means ± SD. n = 4. Mock, negative control mice injected with saline. Statistically significant differences between experimental groups and WT mice injected with Ad are indicated by the star. ∗p < 0.01. Immunity 2009 31, 110-121DOI: (10.1016/j.immuni.2009.04.015) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 6 Confocal Microscopy Analysis of IL-1α Translocation into the Nuclei of MZMϕ in WT and Itgb3−/− Mice Injected with Ad, or WT Mice Injected with AdΔRGD Mutant Mice were injected intravenously with a high dose of the indicated viruses (1011 virus particles per mouse), and 3 hr later spleens were harvested and sections were prepared and stained with DAPI (blue) to detect nuclei of splenocytes, as well as Abs specific for CD169 (green) or IL-1α (red). Confocal images were obtained with a Zeiss 510 Meta Confocal microscope. The physical border of splenic germinal centers are indicated by punctuate lines. Marginal zone macrophages expressing IL-1α are indicated by arrows. Representative pictures are shown. n = 4. Immunity 2009 31, 110-121DOI: (10.1016/j.immuni.2009.04.015) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 7 Transcriptional and Functional Activation of IL-1α in Response to ts1 Mutant Virus (A) Mice were injected with Ad or ts1 mutant and IL-1α mRNA expression was analyzed 30 min later by RNase protection assay. Graphs show mean ± SD. n = 4. Statistically significant differences between experimental groups are indicated by the star. ∗p < 0.01. C, mock-infected mice, treated with saline. AU, arbitrary units. (B) Mouse cytokine array panel showing differences in the proinflammatory cytokines and chemokines in spleen of wild-type (WT) mice injected with Ad or ts1 at indicated doses (virus particles per mouse) 1 hr after virus injection, determined by Proteome Profiler antibody array. Representative blot from three independent experiments is shown. Pos-C are dots that show the manufacturer's internal positive control samples on the membrane. Control, the spleen protein sample of a mouse injected with saline. (C) The amounts of proinflammatory cytokines and chemokines in the spleens of mice 1 hr after Ad or ts1 injection. The amounts of analytes shown on y axis were determined for 50 mg of splenic tissue. Graphs show means ± SD. n = 3. Mock, negative control mice injected with saline. Statistically significant differences between WT mice injected with Ad or ts1 are indicated by the star. ∗p < 0.01. Immunity 2009 31, 110-121DOI: (10.1016/j.immuni.2009.04.015) Copyright © 2009 Elsevier Inc. Terms and Conditions